News
Evercore ISI analyst Vijay Kumar maintained a Buy rating on Enovis today and set a price target of $44.00. The company’s shares opened today at $27.58. Elevate Your Investing St ...
Q3 2025 Earnings Call Transcript August 5, 2025 Azenta, Inc. misses on earnings expectations. Reported EPS is $-1.15519 EPS, expectations were $0.13. Operator: Greetings, and welcome to the Azenta Q3 ...
3d
Fintel on MSNRaymond James Upgrades Azenta (AZTA)
Fintel reports that on August 6, 2025, Raymond James upgraded their outlook for Azenta (NasdaqGS:AZTA) from Market Perform to ...
Gain insights from Azenta's Q3 2025 earnings call. Explore their financial strength, growth strategies, and commitment to 3%-5% revenue growth.
Azenta, Inc. ( NASDAQ: AZTA) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET John P. Marotta - President, CEO & Director Lawrence Y. Lin - Executive VP & CFO Yvonne Perron - Vice President ...
Shares of life sciences company Azenta (NASDAQ:AZTA) fell 16.3% in the afternoon session after the company announced mixed ...
Advanced Micro Devices Inc. earnings are expected to show the chipmaker is increasingly benefiting from the artificial ...
Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year ...
SLS will be returning to Lab Innovations 2025, the UK’s leading trade exhibition for the laboratory industry. Visit us at the NEC Birmingham on 29–30 October, where we’ll be exhibiting on ...
Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday before the bell. Here’s what to look for.
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...
Scientific Laboratory Supplies (SLS) has announced the official rebrand of Sparks under the SLS name and visual identity, which became effective in July 2025. This strategic move marks the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results